USPTO serial 90327437
DR FILL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 1, 2022
- Examiner
- SWIFT, GILBERT M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DR FILL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Yoon S. Ham
Yoon S. Ham HAUPTMAN HAM, LLP2318 MILL ROAD,SUITE 1400ALEXANDRIA, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Health food supplements, namely, health functional food containing crustacean skin or mollusk bone extract; Pharmaceutical preparations for health care for treating erectile dysfunction; Pharmaceutical preparations for health care for treating allergic rhinitis; Pharmaceutical preparations for health care for treating colds; Pharmaceutical preparations for health care for treating pain; Pharmaceutical preparations for health care for treating insomnia; Pharmaceutical preparations for health care for treating dementia; Pharmaceutical preparations for health care for treating indigestion; Pharmaceutical preparations for health care for treating high blood pressure; Pharmaceutical preparations for health care for treating hyperlipidemia; Pharmaceutical preparations for health care for treating diabetes; Pharmaceutical preparations for health care for treating neurasthenia; Pharmaceutical preparations for health care for treating headache; Pharmaceutical preparations for health care for treating gout; Pharmaceutical preparations for health care for treating asthma; Pharmaceutical preparations for health care for treating cancer pain; Pharmaceutical preparations for health care for treating schizophrenia; Pharmaceutical preparations for health care for treating tobaccoism; Pharmaceutical preparations for health care for treating intestinal bacteria; Pharmaceutical preparations for health care for treating respiratory diseases and disorders; Pharmaceutical preparations for health care for treating peptic ulcer; Pharmaceutical preparations for health care for treating intestinal disorders; Health food supplements, namely, health functional food mainly based on nuts; Health food supplements, namely, health functional food mainly based on fruit; Dietary supplements for animals; Medicines for animals, namely, medicinal preparations for treating heart failure; Medicines for animals, namely, medicinal preparations for treating arthritis; Medicines for animals, namely, medicinal preparations for treating heart worm; Medicines for animals, namely, medicinal preparations for treating parasite; Medicines for animals, namely, medicinal preparations for treating parasitic worms; Medicines for animals, namely, medicinal preparations for treating skin conditions; Medicines for animals, namely, medicinal preparations for treating nausea; Medicines for animals, namely, medicinal preparations for treating hyperadrenocorticism; Health food supplements made principally of minerals; Health food supplements, namely, health functional food containing mushroom extract; Health food supplements, namely, health functional food mainly based on mushroom; Health food supplements, namely, health functional food consisting primarily of vitamin, namely, vitamin supplements; Health food supplements, namely, health functional food containing fermented plant extracts; Veterinary substances and preparations, namely, veterinary preparations for treatment of heart failure, veterinary preparations for treatment of arthritis, veterinary preparations for treatment of heart worm, veterinary preparations for treatment of parasite, veterinary preparations for treatment of parasitic worms, veterinary preparations for treatment of skin conditions, veterinary preparations for treatment of nausea, and veterinary preparations for treatment of hyperadrenocorticism; Propolis for pharmaceutical purposes; Health food supplements, namely, health functional food mainly based on fish and shellfish; Propolis for medicinal or therapeutic purposes; Drugs for medical purposes, namely, medicinal preparations for treating erectile dysfunction, medicinal preparations for treating allergic rhinitis, medicinal preparations for treating colds, medicinal preparations for treating pain, medicinal preparations for treating insomnia, medicinal preparations for treating dementia, medicinal preparations for treating indigestion, medicinal preparations for treating high blood pressure, medicinal preparations for treating hyperlipidemia, medicinal preparations for treating diabetes, medicinal preparations for treating neurasthenia, medicinal preparations for treating headache, medicinal preparations for treating gout, medicinal preparations for treating asthma, medicinal preparations for treating cancer pain, medicinal preparations for treating schizophrenia, medicinal preparations for treating tobaccoism, medicinal preparations for treating intestinal bacteria, medicinal preparations for treating respiratory diseases and disorders, medicinal preparations for treating peptic ulcer, and medicinal preparations for treating intestinal disorders; Pharmaceuticals, namely, pharmaceutical preparations for treating erectile dysfunction, pharmaceutical preparations for treating allergic rhinitis, pharmaceutical preparations for treating colds, pharmaceutical preparations for treating pain, pharmaceutical preparations for treating insomnia, pharmaceutical preparations for treating dementia, pharmaceutical preparations for treating indigestion, pharmaceutical preparations for treating high blood pressure, pharmaceutical preparations for treating hyperlipidemia, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating neurasthenia, pharmaceutical preparations for treating headache, pharmaceutical preparations for treating gout, pharmaceutical preparations for treating asthma, pharmaceutical preparations for treating cancer pain, pharmaceutical preparations for treating schizophrenia, pharmaceutical preparations for treating tobaccoism, pharmaceutical preparations for treating intestinal bacteria, pharmaceutical preparations for treating respiratory diseases and disorders, pharmaceutical preparations for treating peptic ulcer, and pharmaceutical preparations for treating intestinal disorders; Medicines for human purposes, namely, analgesics, nervines, antiemetics, hypnotic sedatives, anti-inflammatory and antipyretic preparations, psychotropic agents, medicines for acting on the central nervous system, antihistamines, depressants, medicines for strengthening blood vessels, vasoconstrictors, vasohypotonic, cough expectorants, antacids, cholagogues, medicines for alleviating constipation, enema preparations, androgen preparations, chemosterilants, and antidiabetic preparations; Health food supplements, namely, health functional food mainly based on vegetable; Health food supplements for therapeutic purposes; Propolis dietary supplements; Health food supplements, namely, health functional food containing seaweed extract; Health food supplements, namely, health functional food containing red ginseng extract | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by C.L PHARM.CO., LTD.
- Other trademarks owned by C.L PHARM.CO., LTD.
- Other trademarks owned by C.L PHARM.CO., LTD.
- Other trademarks in Class 005
- Similar marks named DR FILL
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 1, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 14, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 24, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 10, 2021 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 8, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 8, 2021 | DMCC | DATA MODIFICATION COMPLETED | — |
| Nov 8, 2021 | ALIE | ASSIGNED TO LIE | — |
| Nov 6, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 6, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 26, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 26, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 17, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 17, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 17, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 29, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 22, 2021 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jan 21, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 21, 2020 | NWAP | NEW APPLICATION ENTERED | — |